Diagnostic Imaging

2 days ago | diagnosticimaging.com | Jeff Hall

Artificial intelligence (AI) software may significantly enhance coronary artery calcium scoring (CACS) and CAD-RADS stenosis severity evaluation based on coronary computed tomography angiography (CCTA) imaging. For a new retrospective study, recently published in Radiology, researchers assessed the use of an on-premise AI software (Automated Coronary Analysis software, version 4.2.0.0, Siemens Healthineers) for 1,032 patients (median age of 62) who had a total of 1,041 CCTA exams.

2 days ago | diagnosticimaging.com | Jeff Hall

The Food and Drug Administration (FDA) has granted 510(k) clearance for B-Right Views, a device that utilizes artificial intelligence (AI) to help ensure standard fetal heart ultrasound views during second- and third-trimester exams.

3 days ago | diagnosticimaging.com | Jeff Hall

In prognostic models for assessing breast cancer risk, the inclusion of principal components (PCs) of radiomic parenchymal phenotypes, derived from full-field digital mammography (FFDM), was associated with significantly higher AUCs for predicting false-negative cases as well as symptomatic interval cancers.

3 days ago | diagnosticimaging.com | Jeff Hall

The Food and Drug Administration (FDA) has approved an expanded indication that allows use of ultrasound enhancing agent Optison for pediatric patients with suboptimal echocardiograms. Through the use of gas-filled microbubbles, Optison improves the visualization of heart chambers and endocardial borders, according to GE HealthCare, the manufacturer of Optison. Originally approved by the FDA in 1997 for adult patients, Optison was the subject of a recent phase IV multicenter study.

4 days ago | diagnosticimaging.com | Jeff Hall

Emerging results from a new study evaluating artificial intelligence (AI) in digital breast tomosynthesis (DBT) screening for breast cancer shows double the positive predictive value (PPV) for cases with abnormal interpretation and over a 24 percent higher PPV rate for cases proceeding to biopsy. For the retrospective study, recently published in Clinical Breast Cancer, researchers compared unassisted radiologist interpretation of 10,322 DBT screening mammograms vs.